Skip to main content
Clinical Trials/ISRCTN90354265
ISRCTN90354265
Completed
未知

tility of botulinum toxin type A in the treatment of chronic anal fissure

Hospital General Nuestra Señora del Prado0 sites49 target enrollmentFebruary 16, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
Chronic anal fissure
Sponsor
Hospital General Nuestra Señora del Prado
Enrollment
49
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 16, 2024
End Date
June 1, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Hospital General Nuestra Señora del Prado

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged over 18 years
  • 2\. Clinical anal fissure diagnosis for over 2 months that had not responded to previous treatments consisting of dietary and behavioral modifications, analgesics, and local treatment with calcium channel blocker (diltiazem 2%) or nitrates (trinitrate glyceryl 0\.4%)

Exclusion Criteria

  • 1\. Non\-idiopathic anal fissures
  • 2\. Previously untreated patients
  • 3\. BT contraindication such as miastenia gravis, Eaton\-Lambert syndrome, pregnancy, and acetylcholine deficiency

Outcomes

Primary Outcomes

Not specified

Similar Trials